Category: Medical Professional News
What is HSDD? – Patient Resource
Patient Resource – Website What is HSDD? Hypoactive sexual desire dysfunction (HSDD) is an extremely common medical condition that causes distress resulting from a… Continue Reading →
IMS: Sexual wellbeing after menopause
Patient Support Material: Free yourself and embrace positive sexual wellbeing Sexual health is a state of physical, emotional, mental and social wellbeing related to… Continue Reading →
Share your opinions as a woman with POI/ Premature menopause.
International POI guideline update survey What matters for you? A 10 minute scoping survey for women or for health professionals: An international collaboration between the European… Continue Reading →
Jean Hailes: National Women’s Health Survey
National Women’s Health Survey Welcome to Jean Hailes survey This survey was developed by Jean Hailes for Women’s Health and a team of experts…. Continue Reading →
Monash University: Bone Density Study
A study to prevent bone loss and restore sexual function in women with primary ovarian insufficiency Melbourne and Perth As many as 4 in… Continue Reading →
AndroFeme 1 licensed for hypoactive sexual desire dysfunction in postmenopausal women
Lawley Pharmaceuticals has obtained approval for registration of AndroFeme® 1 in the Australian Register of Therapeutic Goods (ARTG) for the treatment of postmenopausal women… Continue Reading →
Tanner Pharma Group and Lawley Pharmaceuticals Initiate Global Named Patient Program for AndroFeme® 1
Friday 12th June 2020 Perth, Australia and Charlotte, USA – Lawley Pharmaceuticals and Tanner Pharma Group announced today that they have initiated a global… Continue Reading →
TGA accepts AndroFeme 1 for evaluation in postmenopausal women with Hypoactive Sexual Desire Dysfunction.
TGA accepts AndroFeme 1 for evaluation in postmenopausal women with HSDD. Perth, Western Australia; Dec. 05, 2019 — Lawley Pharmaceuticals today announced AndroFeme 1,… Continue Reading →
Global Consensus Position Statement on the Use of Testosterone Therapy for Women
The Global Consensus Position Statement on the Use of Testosterone Therapy for Women was simultaneously published on the 2nd September 2019 in Maturitas, Journal… Continue Reading →
Gender disparity in sexual health options for women: Experts call on pharma and drug regulators to address
In 2015 Comment in the prestigious medical journal Lancet Diabetes & Endocrinology by two of the world’s leading female sexual health specialists, Prof. Susan Davis (Australia)… Continue Reading →